Deficiency Index

Every finding on record at Tender Loving Hospice Care, Inc.

Pasadena, California · CCN B21510

3 findings across 1 survey, in the inspector's own words.

The inspector’s own words from form CMS-2567, unedited, including CMS’s own spacing. Names and some dates are redacted by CMS.

Survey of September 22, 2023

3 findings
L0530

Upon patient record review, 3 of 14 (Patient 2, 8 & 10) did not have evidence in the patient record that a review was completed of all prescription and non-prescription medications, including herbal remedies that could affect drug therapy. This review includes, but is not limited to: • Effectiveness of drug therapy • Drug side effects • Actual or potential drug interactions • Duplicate drug therapy • Drug therapy currently associated with laboratory monitoring Patient 2 medication profile included “Creon 120,000 units orally, 24000 units three to four times daily” with unclear frequency. Patient 8 medication profile included “A&D ointment topically apply to all high-pressure areas daily as needed for redness/irritation” with location unclear. “Ca-rezz cream topically apply to all high-pressure areas daily as needed for redness/irritation” with location unclear. Patient 10 medication profile included “Ca-rezz cream topically apply to all high pressure areas daily as needed for redness/irritation” with location unclear. “Loperamide Hydrochloride 2mg oral tab, take 2 tabs after the first loose stool, then 1 tab after each loose stool daily as needed for diarrhea” with no daily dosage limit indicated.

L0549

Upon patient record review, 3 of 14 (Patient 2, 8 &10) did not have evidence the plan of care must include all services necessary for the palliation and management of the terminal illness and related conditions, including medications and treatments. Patient 2 plan of care included “Creon 120,000 units orally, 24000 units three to four times daily” with unclear frequency. Patient 8 plan of care included “A&D ointment topically apply to all high-pressure areas daily as needed for redness/irritation” with location unclear. “Ca-rezz cream topically apply to all high-pressure areas daily as needed for redness/irritation” with location unclear. Patient 10 plan of care included “Ca-rezz cream topically apply to all high pressure areas daily as needed for redness/irritation” with location unclear. “Loperamide Hydrochloride 2mg oral tab, take 2 tabs after the first loose stool, then 1 tab after each loose stool daily as needed for diarrhea” with no daily dosage limit indicated.

L0555

Upon client record review, 3 of 14 (Patient 5, 10 & 12) did not have evidence that the IDG ensures that the care and services are provided in accordance with the plan of care. Patient 5 plan of care notes “LVN/SN visits once weekly”. No evidence of SN visit week of 9/3-9/9/23 and no missed visit communication. Patient 10 MD order dated 6/8/23 “SN to perform wound care 3 x weekly”. Frequency unmet for weeks of: 6/11-6/17: SN x 2 visits made and no missed visit communication. 6/25-7/1: SN x 2 visits made and no missed visit communication. 7/2-7/8: SN x 2 visits made and no missed visit communication. 7/9-7/15: SN x 1 visit made and no missed visit communication. Patient 12 plan of care notes "SN visits 1 x weekly" No evidence of SN visit 7/9-7/15 and no evidence of missed visit notes. No evidence of SN visit 7/23-7/29 and no evidence of missed visit notes.

← Back to the Tender Loving Hospice Care, Inc. record

Federal survey findings only. State licensure findings for hospices are not shown.

Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction